NASDAQ:MANHManhattan Associates Stock Price, Forecast & News

Manhattan Associates' stock was trading at $64.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MANH shares have decreased by 9.9% and is now trading at $57.75. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Associates in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Manhattan Associates.

Manhattan Associates is scheduled to release its next quarterly earnings announcement on Tuesday, April 21st 2020. View our earnings forecast for Manhattan Associates.

Manhattan Associates will be holding an earnings conference call on Tuesday, April 21st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Manhattan Associates, Inc. (NASDAQ:MANH) announced its quarterly earnings results on Tuesday, February, 4th. The software maker reported $0.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.09. The software maker had revenue of $152.90 million for the quarter, compared to analyst estimates of $147.58 million. Manhattan Associates had a return on equity of 58.03% and a net margin of 13.88%. The company's revenue was up 5.9% on a year-over-year basis. During the same period last year, the company posted $0.46 EPS. View Manhattan Associates' earnings history.

Manhattan Associates updated its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $1.53-1.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.54. The company issued revenue guidance of $644-656 million, compared to the consensus revenue estimate of $649.63 million.

5 analysts have issued 12 month price objectives for Manhattan Associates' shares. Their forecasts range from $80.00 to $100.00. On average, they anticipate Manhattan Associates' stock price to reach $92.25 in the next twelve months. This suggests a possible upside of 59.7% from the stock's current price. View analysts' price targets for Manhattan Associates.

Media coverage about MANH stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Manhattan Associates earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news articles about the software maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutManhattan Associates.

Manhattan Associates saw a increase in short interest in the month of March. As of March 13th, there was short interest totaling 5,245,600 shares, an increase of 11.4% from the February 27th total of 4,710,000 shares. Based on an average daily volume of 753,000 shares, the short-interest ratio is currently 7.0 days. Approximately 8.3% of the company's shares are short sold. View Manhattan Associates' Current Options Chain.

Some companies that are related to Manhattan Associates include Adobe (ADBE), salesforce.com (CRM), Intuit (INTU), Workday (WDAY), Autodesk (ADSK), ANSYS (ANSS), Synopsys (SNPS), Cadence Design Systems (CDNS), Splunk (SPLK), Citrix Systems (CTXS), Tyler Technologies (TYL), SS&C Technologies (SSNC), FactSet Research Systems (FDS), Fair Isaac (FICO) and Guidewire Software (GWRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Associates investors own include Nike (NKE), AT&T (T), Broadcom (AVGO), Gilead Sciences (GILD), Starbucks (SBUX), Visa (V), Skyworks Solutions (SWKS), AbbVie (ABBV), Allergan (AGN) and Southwest Airlines (LUV).

Manhattan Associates trades on the NASDAQ under the ticker symbol "MANH."

Manhattan Associates' stock is owned by many different institutional and retail investors. Top institutional shareholders include M&G Investment Management Ltd. (0.77%), State of Alaska Department of Revenue (0.02%) and Contravisory Investment Management Inc. (0.00%). Company insiders that own Manhattan Associates stock include Bruce Richards, Dennis B Story, Eddie Capel, Edmond Eger, John J Huntz Jr and Robert G Howell. View institutional ownership trends for Manhattan Associates.

MANH stock was sold by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd.. Company insiders that have sold Manhattan Associates company stock in the last year include Dennis B Story, Eddie Capel, and John J Huntz Jr. View insider buying and selling activity for Manhattan Associates.

MANH stock was purchased by a variety of institutional investors in the last quarter, including Contravisory Investment Management Inc., and State of Alaska Department of Revenue. View insider buying and selling activity for Manhattan Associates.

Shares of MANH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MANH stock can currently be purchased for approximately $57.75.

Manhattan Associates has a market capitalization of $3.67 billion and generates $617.95 million in revenue each year. The software maker earns $85.76 million in net income (profit) each year or $1.32 on an earnings per share basis. Manhattan Associates employs 3,400 workers across the globe. View additional information about Manhattan Associates.

The official website for Manhattan Associates is http://www.manh.com/.

Manhattan Associates' mailing address is 2300 WINDY RIDGE PARKWAY TENTH FLOOR, ATLANTA GA, 30339. The software maker can be reached via phone at 770-955-7070 or via email at [email protected]